“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: P61 A deadly sore throat: acquired-TTP or Clindamycin induced thrombotic microangiopathy

€3.03

SKU: product-article-16403 Category: General

Description
Reviews (0)

Description

P61 A deadly sore throat: acquired-TTP or Clindamycin induced thrombotic microangiopathy

Reviews

There are no reviews yet.

Be the first to review “Article: P61 A deadly sore throat: acquired-TTP or Clindamycin induced thrombotic microangiopathy”

You must be logged in to post a review.

Top

Article: P61 A deadly sore throat: acquired-TTP or Clindamycin induced thrombotic microangiopathy

Description

Reviews

Related products

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Highlights in melanoma

Article: Highlights in digestive oncology

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer